11.21
price down icon0.88%   -0.10
after-market 시간 외 거래: 11.21
loading

Pliant Therapeutics Inc 주식(PLRX)의 최신 뉴스

pulisher
Sep 30, 2024

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Bakersfield Californian

Sep 30, 2024
pulisher
Sep 30, 2024

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 30, 2024
pulisher
Sep 30, 2024

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

11,678 Shares in Pliant Therapeutics, Inc. (NASDAQ:PLRX) Acquired by Deerfield Management Company L.P. Series C - Defense World

Sep 30, 2024
pulisher
Sep 28, 2024

Pliant Therapeutics updates bylaws, aligns with Delaware law By Investing.com - Investing.com South Africa

Sep 28, 2024
pulisher
Sep 27, 2024

Pliant Therapeutics updates bylaws, aligns with Delaware law By Investing.com - Investing.com UK

Sep 27, 2024
pulisher
Sep 25, 2024

Investing in Pliant Therapeutics Inc (PLRX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Pliant Therapeutics Inc (PLRX) receives an Outperform rating from Leerink Partners - Knox Daily

Sep 25, 2024
pulisher
Sep 25, 2024

Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains

Sep 25, 2024
pulisher
Sep 25, 2024

5,372 Shares in Piper Sandler Companies (NYSE:PIPR) Purchased by Intech Investment Management LLC - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Berkley W R Corp Cuts Stock Position in Plum Acquisition Corp. I (NASDAQ:PLMI) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Raises Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Priority Technology (NASDAQ:PRTH) Reaches New 1-Year High After Analyst Upgrade - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Sold by First Light Asset Management LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

First Light Asset Management LLC Sells 133,780 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Palfinger (OTCMKTS:PLFRY) Trading Down 2% - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Pulse Biosciences Inc [PLSE] Investment Appeal on the Rise - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Rhumbline Advisers Raises Stock Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Piper Sandler Companies (NYSE:PIPR) Shares Acquired by Commonwealth Equity Services LLC - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Pliant Therapeutics (NASDAQ:PLRX) Trading Down 2.7% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Piper Sandler Companies (NYSE:PIPR) Rating Reiterated by JMP Securities - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

JMP Securities Reaffirms “Market Perform” Rating for Piper Sandler Companies (NYSE:PIPR) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Pliant Therapeutics (NASDAQ:PLRX) Stock Price Down 2.7% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

PLRX’s 52-Week Rollercoaster: From $10.29 to $19.62 – What’s Next for Investors? - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Piper Sandler maintains Overweight rating on Pliant Therapeutics shares By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

What is the investor’s view on Pliant Therapeutics Inc (PLRX)? - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Statera Biopharma (NASDAQ:STAB) & Pliant Therapeutics (NASDAQ:PLRX) Financial Analysis - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Purchased by Bank of New York Mellon Corp - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

PLRX’s latest rating updates from top analysts. - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $12.00 - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Ratio Review: Analyzing Pliant Therapeutics Inc (PLRX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 16, 2024
pulisher
Sep 16, 2024

This trade activity should not be overlooked: Pliant Therapeutics Inc (PLRX) - SETE News

Sep 16, 2024
pulisher
Sep 15, 2024

HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX) - Defense World

Sep 15, 2024
pulisher
Sep 14, 2024

Quest Partners LLC Has $346,000 Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World

Sep 14, 2024
pulisher
Sep 14, 2024

Analysts Set Pliant Therapeutics, Inc. (NASDAQ:PLRX) Target Price at $40.57 - MarketBeat

Sep 14, 2024
pulisher
Sep 14, 2024

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX) - MarketBeat

Sep 13, 2024
pulisher
Sep 13, 2024

Is Pliant Therapeutics (NASDAQ:PLRX) Using Too Much Debt? - Simply Wall St

Sep 13, 2024
pulisher
Sep 12, 2024

Rice Hall James & Associates LLC Takes $1.37 Million Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

Research Analysts Set Expectations for Pliant Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:PLRX) - Defense World

Sep 12, 2024
pulisher
Sep 12, 2024

Brokers Set Expectations for Pliant Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:PLRX) - MarketBeat

Sep 12, 2024
pulisher
Sep 11, 2024

Pliant Therapeutics: Good Data, But Will Need Watching (NASDAQ:PLRX) - Seeking Alpha

Sep 11, 2024
pulisher
Sep 11, 2024

Pliant Therapeutics (NASDAQ:PLRX) Shares Down 4.2% - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Forecasted to Post Q1 2025 Earnings of ($0.97) Per Share - Defense World

Sep 11, 2024
pulisher
Sep 11, 2024

Pliant Therapeutics (NASDAQ:PLRX) Stock Rating Upgraded by Leerink Partnrs - Defense World

Sep 11, 2024
pulisher
Sep 10, 2024

Trend Tracker for (PLRX) - Stock Traders Daily

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024 - Markets Insider

Sep 10, 2024
pulisher
Sep 10, 2024

Leerink Partnrs Comments on Pliant Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:PLRX) - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics (NASDAQ:PLRX) Lifted to "Strong-Buy" at Leerink Partnrs - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics Presents Data from its Bexotegrast - GlobeNewswire

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory - The Bakersfield Californian

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024 - StockTitan

Sep 10, 2024
pulisher
Sep 10, 2024

Pliant Therapeutics (NASDAQ:PLRX) Coverage Initiated by Analysts at Leerink Partners - Defense World

Sep 10, 2024
pulisher
Sep 09, 2024

Candriam S.C.A. Has $8.96 Million Stock Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - MarketBeat

Sep 09, 2024
pulisher
Sep 09, 2024

Leerink Partners sets Outperform rating on Pliant Therapeutics shares By Investing.com - Investing.com Canada

Sep 09, 2024
pulisher
Sep 09, 2024

Pliant Therapeutics (NASDAQ:PLRX) Coverage Initiated at Leerink Partners - MarketBeat

Sep 09, 2024
pulisher
Sep 09, 2024

Candriam S.C.A. Boosts Stock Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World

Sep 09, 2024
pulisher
Aug 28, 2024

Pliant Therapeutics to Participate in Upcoming Investor Events - GlobeNewswire

Aug 28, 2024
pulisher
Aug 28, 2024

Pliant Therapeutics to Participate in Upcoming Investor Events - StockTitan

Aug 28, 2024
pulisher
Aug 28, 2024

Pliant Therapeutics to Participate in Upcoming Investor Events - Yahoo Finance

Aug 28, 2024
pulisher
Aug 27, 2024

Taking a Closer Look At Pliant Therapeutics Inc (PLRX) Following Its Recent Trade - Knox Daily

Aug 27, 2024
pulisher
Aug 26, 2024

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - Markets Insider

Aug 26, 2024
pulisher
Aug 26, 2024

There is no way Pliant Therapeutics Inc (PLRX) can keep these numbers up - SETE News

Aug 26, 2024
pulisher
Aug 26, 2024

Investor’s Toolkit: Key Ratios for Assessing Pliant Therapeutics Inc (PLRX)’s Performance - The Dwinnex

Aug 26, 2024
pulisher
Aug 26, 2024

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - ForexTV.com

Aug 26, 2024
pulisher
Aug 26, 2024

Pliant Therapeutics Announces Four Upcoming Presentations - GlobeNewswire

Aug 26, 2024
pulisher
Aug 26, 2024

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - StockTitan

Aug 26, 2024
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
자본화:     |  볼륨(24시간):